Product Details for: Anthim

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
600MG/6ML (100MG/ML)
Single-Dose Vial
351(a)
Anthim
Rx
Proper Name
obiltoxaximab
BLA Number
125509
Applicant
Elusys Therapeutics, Inc.
Original Approval Date
March 18, 2016
Date of First Licensure
RETURN TO SEARCH RESULTS